DocMorris Aktie
WKN DE: A0Q6J0 / ISIN: CH0042615283
15.07.2025 07:00:04
|
gematik extends DocMorris CardLink approval until January 2027
DocMorris AG
/ Key word(s): Miscellaneous
Frauenfeld, 15 July 2025 Press release gematik extends DocMorris CardLink approval until January 2027
gematik has extended the product approval for DocMorris' CardLink solution until the end of January 2027. Patients can therefore continue to redeem their e-prescriptions with their electronic health card (eGK) and the DocMorris app, while at the same time a seamless transition to the successor technology PoPP (Proof of Patient Presence) is ensured. “We welcome the fact that gematik worked with all parties involved at an early stage to find a transitional arrangement for fully digital e-prescription redemption until the nationwide introduction of PoPP. By enabling the contactless use of the eGK without a PIN, even in the context of PoPP, our customers can continue to rely on learned redemption methods for their e-prescriptions in the future,” says Walter Hess, CEO DocMorris.
Investors and analyst contact Media contact Agenda
DocMorris
End of Media Release |
Language: | English |
Company: | DocMorris AG |
Walzmühlestrasse 49 | |
8500 Frauenfeld | |
Switzerland | |
ISIN: | CH0042615283 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2169628 |
End of News | EQS News Service |
|
2169628 15.07.2025 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DocMorris AG (ex Zur Rose)mehr Nachrichten
17.10.25 |
Angespannte Stimmung in Zürich: SPI schlussendlich in Rot (finanzen.at) | |
17.10.25 |
Anleger in Zürich halten sich zurück: SPI legt am Freitagnachmittag den Rückwärtsgang ein (finanzen.at) | |
17.10.25 |
Verluste in Zürich: So bewegt sich der SPI aktuell (finanzen.at) | |
17.10.25 |
Börse Zürich in Rot: SPI gibt zum Start nach (finanzen.at) | |
16.10.25 |
Pluszeichen in Zürich: SPI letztendlich fester (finanzen.at) | |
16.10.25 |
Handel in Zürich: SPI zeigt sich am Donnerstagnachmittag fester (finanzen.at) | |
16.10.25 |
DocMorris beschleunigt sequenzielles Rx-Wachstum und steigert Non-Rx-Umsätze (EQS Group) | |
16.10.25 |
DocMorris accelerates sequential Rx growth and increases non-Rx revenue (EQS Group) |
Analysen zu DocMorris AG (ex Zur Rose)mehr Analysen
17.10.25 | DocMorris Hold | Deutsche Bank AG | |
17.10.25 | DocMorris Sell | UBS AG | |
16.10.25 | DocMorris Sell | UBS AG | |
16.10.25 | DocMorris Add | Baader Bank | |
16.10.25 | DocMorris Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
DocMorris AG (ex Zur Rose) | 6,70 | -6,82% |
|